Published :
Tables : 43
Figures : 41
Category : Healthcare
No. of Pages : 210
Report Code : HC-1278
Cardiac Monitoring and Cardiac Rhythm Management Devices Market is poised to value over CAGR of over 3.8% during the forecast period 2022 to 2028. The surge of patients suffering from ailments such as heart failure and recurrent arrhythmias has contributed significantly to the cardiac rhythm management (CRM) devices market. This market has seen exponential growth due to technological progress, cardiac disorders, a greater awareness among patients and a rise in the untreated medical conditions in developing nations. But despite all the advancements, the market still encounters some hindrances such as the exorbitant costs, lack of insurance coverage alternatives and an inclination to choose drugs over treatment devices. All these factors are especially prevalent in developing nations. Having said that, the developments in the latest MRI-labeled devices, along with the growth in the economies of LAMEA and Asia-Pacific regions have been predicted to augment the growth of the industries involved in the manufacture of cardiac rhythm management and cardiac monitoring. Segmentation-wise, the market has been bifurcated into cardiac rhythm management and cardiac monitoring. These two segments have been divided into cardiac rhythm management devices and conventional monitoring devices. Here, the monitoring device has been categorised into event monitors, cardiac monitors, ECG, Holter monitors and ILR (implantable loop recorder). Cardiac rhythm management (CRM) has been classified into sub-segments which includes defibrillators, pacemakers and cardiac resynchronization devices. Electrocardiography (ECG) market has been anticipated to account for the largest segment in the forecast time frame, while ILR is predicted to be the fastest growing segment and pacemakers and defibrillators are widely used in the area of diagnostics. These are likely to exhibit robust growth in the next six years because they are, in fact, the most mature market. Cardiac telemetry and ECG data management are two such systems that are highly up to date and will demonstrate positive changes in the ambulatory and home health care services. The segmentation of the end users are home health care facilities, hospitals and ambulatory services. The ease of treatment and the affordability of the ambulatory and home health care facilities rank as some of the main factors in the substantial market growth. Major players included in the Cardiac Monitoring and Cardiac Rhythm Management Devices Market: • Medtronic • Boston Scientific • Abbott Laboratories • GE Healthcare • BIOTRONIK • Koninklijke Philips • Asahi Kasei • MicroPort Scientific • Hill-Rom Holdings • Nihon Kohden • SCHILLER AG • BioTelemetry • BPL Medical Technologies • ACS Diagnostics • Shenzhen Mindray Bio-Medical Electronics • Lepu Medical Technology • Shree Pacetronix • OSYPKA • BTL • Alivecor, Inc. • Amiitalia • Bexen Cardio • Narang Medical Limited • MeTrax GmbH • Progetti Srl (Note: The list of the major players will be updated with the latest market scenario and trends) Cardiac Monitoring and & Cardiac Rhythm Management Devices Market Segmentation: By Type • ECG Devices o Resting ECG Devices o Stress ECG Devices o Holter Monitors • Implantable Loop Recorders • Mobile Cardiac Telemetry Devices • Cardiac Output Monitoring Devices • Event Monitors o Event Monitors Market, by Type • Pre-symptom Event Monitors • Post-symptom Event Monitors o Event Monitors Market, by Technology • Autodetect Monitors • Manual Event Monitors o Smart ECG Monitors • Defibrillators o Implantable Cardioverter Defibrillators • Transvenous Implantable Cardioverter Defibrillators (T-ICDs) o Biventricular Implantable Cardioverter Defibrillators/Cardiac Resynchronization Therapy Defibrillators o Dual-Chamber Implantable Cardioverter Defibrillators o Single-Chamber Implantable Cardioverter Defibrillators • Subcutaneous Implantable Cardioverter Defibrillators (T-ICDs) o External Defibrillators • Automated External Defibrillators o Semi-Automated External Defibrillators o Fully Automated External Defibrillators • Manual External Defibrillators • Wearable Cardioverter Defibrillators o Pacemakers • Pacemakers Market, By Implantability o Implantable Pacemakers o External Pacemakers • Pacemakers Market, By Type o Dual-Chamber Pacemakers o Single-Chamber Pacemakers o Biventricular/Crt Pacemakers By End User • Hospitals • Clinics, Cardiac Centers and Ambulatory Surgery Centers • Other End Users By Region • North America • Europe • Asia Pacific • Latin America • Middle East and Africa Cardiac Monitoring and Cardiac Rhythm Management Devices Market Video Sample: Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Cardiac Monitoring and Cardiac Rhythm Management Devices Market By Type, By End User and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
The surge of patients suffering from ailments such as heart failure and recurrent arrhythmias has contributed significantly to the cardiac rhythm management (CRM) devices market. This market has seen exponential growth due to technological progress, cardiac disorders, a greater awareness among patients and a rise in the untreated medical conditions in developing nations. But despite all the advancements, the market still encounters some hindrances such as the exorbitant costs, lack of insurance coverage alternatives and an inclination to choose drugs over treatment devices. All these factors are especially prevalent in developing nations. Having said that, the developments in the latest MRI-labeled devices, along with the growth in the economies of LAMEA and Asia-Pacific regions have been predicted to augment the growth of the industries involved in the manufacture of cardiac rhythm management and cardiac monitoring.
Segmentation-wise, the market has been bifurcated into cardiac rhythm management and cardiac monitoring. These two segments have been divided into cardiac rhythm management devices and conventional monitoring devices. Here, the monitoring device has been categorised into event monitors, cardiac monitors, ECG, Holter monitors and ILR (implantable loop recorder). Cardiac rhythm management (CRM) has been classified into sub-segments which includes defibrillators, pacemakers and cardiac resynchronization devices.
Electrocardiography (ECG) market has been anticipated to account for the largest segment in the forecast time frame, while ILR is predicted to be the fastest growing segment and pacemakers and defibrillators are widely used in the area of diagnostics. These are likely to exhibit robust growth in the next six years because they are, in fact, the most mature market. Cardiac telemetry and ECG data management are two such systems that are highly up to date and will demonstrate positive changes in the ambulatory and home health care services.
The segmentation of the end users are home health care facilities, hospitals and ambulatory services. The ease of treatment and the affordability of the ambulatory and home health care facilities rank as some of the main factors in the substantial market growth.
Major players included in the Cardiac Monitoring and Cardiac Rhythm Management Devices Market: • Medtronic • Boston Scientific • Abbott Laboratories • GE Healthcare • BIOTRONIK • Koninklijke Philips • Asahi Kasei • MicroPort Scientific • Hill-Rom Holdings • Nihon Kohden • SCHILLER AG • BioTelemetry • BPL Medical Technologies • ACS Diagnostics • Shenzhen Mindray Bio-Medical Electronics • Lepu Medical Technology • Shree Pacetronix • OSYPKA • BTL • Alivecor, Inc. • Amiitalia • Bexen Cardio • Narang Medical Limited • MeTrax GmbH • Progetti Srl (Note: The list of the major players will be updated with the latest market scenario and trends)
Cardiac Monitoring and & Cardiac Rhythm Management Devices Market Segmentation:
By Type • ECG Devices o Resting ECG Devices o Stress ECG Devices o Holter Monitors • Implantable Loop Recorders • Mobile Cardiac Telemetry Devices • Cardiac Output Monitoring Devices • Event Monitors o Event Monitors Market, by Type • Pre-symptom Event Monitors • Post-symptom Event Monitors o Event Monitors Market, by Technology • Autodetect Monitors • Manual Event Monitors o Smart ECG Monitors • Defibrillators o Implantable Cardioverter Defibrillators • Transvenous Implantable Cardioverter Defibrillators (T-ICDs) o Biventricular Implantable Cardioverter Defibrillators/Cardiac Resynchronization Therapy Defibrillators o Dual-Chamber Implantable Cardioverter Defibrillators o Single-Chamber Implantable Cardioverter Defibrillators • Subcutaneous Implantable Cardioverter Defibrillators (T-ICDs) o External Defibrillators • Automated External Defibrillators o Semi-Automated External Defibrillators o Fully Automated External Defibrillators • Manual External Defibrillators • Wearable Cardioverter Defibrillators o Pacemakers • Pacemakers Market, By Implantability o Implantable Pacemakers o External Pacemakers • Pacemakers Market, By Type o Dual-Chamber Pacemakers o Single-Chamber Pacemakers o Biventricular/Crt Pacemakers
By End User • Hospitals • Clinics, Cardiac Centers and Ambulatory Surgery Centers • Other End Users
By Region • North America • Europe • Asia Pacific • Latin America • Middle East and Africa
Cardiac Monitoring and Cardiac Rhythm Management Devices Market Video Sample:
Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants
FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth
Objectives of the Study: • To provide with an exhaustive analysis on the Cardiac Monitoring and Cardiac Rhythm Management Devices Market By Type, By End User and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Cardiac Monitoring and Cardiac Rhythm Management Devices Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Type Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Cardiac Monitoring and Cardiac Rhythm Management Devices Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Cardiac Monitoring and Cardiac Rhythm Management Devices Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Type Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Type Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. ECG Devices 7.1.1. Resting ECG Devices 7.1.2. Stress ECG Devices 7.1.3. Holter Monitors 7.2. Implantable Loop Recorders 7.3. Mobile Cardiac Telemetry Devices 7.4. Cardiac Output Monitoring Devices 7.5. Event Monitors 7.5.1. Event Monitors Market, by Type 7.5.1.1. Pre-symptom Event Monitors 7.5.1.1. Post-symptom Event Monitors 7.5.2. Event Monitors Market, by Technology 7.5.2.1. Autodetect Monitors 7.5.2.1. Manual Event Monitors 7.5.3. Smart ECG Monitors 7.6. Defibrillators 7.6.1. Implantable Cardioverter Defibrillators 7.6.1.1. Transvenous Implantable Cardioverter Defibrillators (T-ICDs) 7.6.1.1.1. Biventricular Implantable Cardioverter Defibrillators/Cardiac Resynchronization Therapy Defibrillators 7.6.1.1.2. Dual-Chamber Implantable Cardioverter Defibrillators 7.6.1.1.3. Single-Chamber Implantable Cardioverter Defibrillators 7.6.1.2. Subcutaneous Implantable Cardioverter Defibrillators (T-ICDs) 7.6.2. External Defibrillators 7.6.2.1. Automated External Defibrillators 7.6.2.2.1. Semi-Automated External Defibrillators 7.6.2.2.2. Fully Automated External Defibrillators 7.6.2.2. Manual External Defibrillators 7.6.2.3. Wearable Cardioverter Defibrillators 7.6.3. Pacemakers 7.6.3.1. Pacemakers Market, By Implantability 7.6.3.3.1. Implantable Pacemakers 7.6.3.3.2. External Pacemakers 7.6.3.1. Pacemakers Market, By Type 7.6.3.3.1. Dual-Chamber Pacemakers 7.6.3.3.2. Single-Chamber Pacemakers 7.6.3.3.3. Biventricular/Crt Pacemakers 8. Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By End-User Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Hospitals 8.2. Clinics, Cardiac Centers and Ambulatory Surgery Centers 8.3. Other End Users 9. North America Cardiac Monitoring and Cardiac Rhythm Management Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 9.2.1. U.S.A 9.2.2. Canada 9.2.3. Mexico 9.3. Market Size (USD Million) Forecast for North America 2022-2028 10. Latin America Cardiac Monitoring and Cardiac Rhythm Management Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. Brazil 10.2.2. Venezuela 10.2.3. Argentina 10.2.4. Rest of Latin America 10.3. Market Size (USD Million) Forecast for Latin America 2022-2028 11. Europe Cardiac Monitoring and Cardiac Rhythm Management Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5. Spain 11.2.6. Russia 11.2.7. Poland 11.2.8. Rest of Europe 11.3. Market Size (USD Million) Forecast for Europe 2022-2028 12. Asia Pacific Cardiac Monitoring and Cardiac Rhythm Management Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Japan 12.2.2. China 12.2.3. India 12.2.4. Australia and New Zealand 12.2.5. ASEAN 12.2.6. Rest of Asia Pacific 12.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 13. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. GCC 13.2.2. Israel 13.2.3. South Africa 13.2.4. Rest of MEA 13.3. Market Size (USD Million) Forecast for MEA 2022-2028 14. Market Share Analysis and Competitive Landscape 14.1. Global Landscape - Key Players, Revenue and Presence 14.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 14.3. Global Emerging Companies 14.4. North America - Market Share Analysis and Key Regional Players 14.5. Europe - Market Share Analysis and Key Regional Players 14.6. Asia Pacific - Market Share Analysis and Key Regional Players 14.7. Global Key Player - Growth Matrix 15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 15.1. Medtronic 15.1.1. Company Overview 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2. Boston Scientific 15.2.1. Company Overview 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3. Abbott Laboratories 15.3.1. Company Overview 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4. GE Healthcare 15.4.1. Company Overview 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5. BIOTRONIK 15.5.1. Company Overview 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6. Koninklijke Philips 15.6.1. Company Overview 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7. Asahi Kasei 15.7.1. Company Overview 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8. MicroPort Scientific 15.8.1. Company Overview 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9. Hill-Rom Holdings 15.9.1. Company Overview 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 15.10.Nihon Kohden 15.10.1. Company Overview 15.10.2. Product Portfolio 15.10.3. SWOT Analysis 15.10.4. Financial Overview 15.10.5. Strategic Overview 15.11.SCHILLER AG 15.11.1. Company Overview 15.11.2. Product Portfolio 15.11.3. SWOT Analysis 15.11.4. Financial Overview 15.11.5. Strategic Overview 15.12.BioTelemetry 15.12.1. Company Overview 15.12.2. Product Portfolio 15.12.3. SWOT Analysis 15.12.4. Financial Overview 15.12.5. Strategic Overview 15.13.BPL Medical Technologies 15.13.1. Company Overview 15.13.2. Product Portfolio 15.13.3. SWOT Analysis 15.13.4. Financial Overview 15.13.5. Strategic Overview 15.14.ACS Diagnostics 15.14.1. Company Overview 15.14.2. Product Portfolio 15.14.3. SWOT Analysis 15.14.4. Financial Overview 15.14.5. Strategic Overview 15.15.Shenzhen Mindray Bio-Medical Electronics 15.15.1. Company Overview 15.15.2. Product Portfolio 15.15.3. SWOT Analysis 15.15.4. Financial Overview 15.15.5. Strategic Overview 15.16.Lepu Medical Technology 15.16.1. Company Overview 15.16.2. Product Portfolio 15.16.3. SWOT Analysis 15.16.4. Financial Overview 15.16.5. Strategic Overview 15.17.Shree Pacetronix 15.17.1. Company Overview 15.17.2. Product Portfolio 15.17.3. SWOT Analysis 15.17.4. Financial Overview 15.17.5. Strategic Overview 15.18.OSYPKA 15.18.1. Company Overview 15.18.2. Product Portfolio 15.18.3. SWOT Analysis 15.18.4. Financial Overview 15.18.5. Strategic Overview 15.19.BTL 15.19.1. Company Overview 15.19.2. Product Portfolio 15.19.3. SWOT Analysis 15.19.4. Financial Overview 15.19.5. Strategic Overview 15.20.Alivecor, Inc. 15.20.1. Company Overview 15.20.2. Product Portfolio 15.20.3. SWOT Analysis 15.20.4. Financial Overview 15.20.5. Strategic Overview 15.21.Amiitalia 15.21.1. Company Overview 15.21.2. Product Portfolio 15.21.3. SWOT Analysis 15.21.4. Financial Overview 15.21.5. Strategic Overview 15.22.Bexen Cardio 15.22.1. Company Overview 15.22.2. Product Portfolio 15.22.3. SWOT Analysis 15.22.4. Financial Overview 15.22.5. Strategic Overview 15.23.Narang Medical Limited 15.23.1. Company Overview 15.23.2. Product Portfolio 15.23.3. SWOT Analysis 15.23.4. Financial Overview 15.23.5. Strategic Overview 15.24.MeTrax GmbH 15.24.1. Company Overview 15.24.2. Product Portfolio 15.24.3. SWOT Analysis 15.24.4. Financial Overview 15.24.5. Strategic Overview 15.25.Progetti Srl 15.25.1. Company Overview 15.25.2. Product Portfolio 15.25.3. SWOT Analysis 15.25.4. Financial Overview 15.25.5. Strategic Overview 16. Pre and Post COVID-19 Impact 16.1. Positive influence on the healthcare industry 16.2. The financial disruption of the manufacturing sector 16.3. Impact of COVID-19 on emerging companies 16.4. Significant mandates in the healthcare regulations initiated by administrations 16.5. The overall economic slowdown of the developing and developed nations 17. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Cardiac Monitoring and Cardiac Rhythm Management Devices Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Type Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Cardiac Monitoring and Cardiac Rhythm Management Devices Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Cardiac Monitoring and Cardiac Rhythm Management Devices Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Type Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Type Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. ECG Devices 7.1.1. Resting ECG Devices 7.1.2. Stress ECG Devices 7.1.3. Holter Monitors 7.2. Implantable Loop Recorders 7.3. Mobile Cardiac Telemetry Devices 7.4. Cardiac Output Monitoring Devices 7.5. Event Monitors 7.5.1. Event Monitors Market, by Type 7.5.1.1. Pre-symptom Event Monitors 7.5.1.1. Post-symptom Event Monitors 7.5.2. Event Monitors Market, by Technology 7.5.2.1. Autodetect Monitors 7.5.2.1. Manual Event Monitors 7.5.3. Smart ECG Monitors 7.6. Defibrillators 7.6.1. Implantable Cardioverter Defibrillators 7.6.1.1. Transvenous Implantable Cardioverter Defibrillators (T-ICDs) 7.6.1.1.1. Biventricular Implantable Cardioverter Defibrillators/Cardiac Resynchronization Therapy Defibrillators 7.6.1.1.2. Dual-Chamber Implantable Cardioverter Defibrillators 7.6.1.1.3. Single-Chamber Implantable Cardioverter Defibrillators 7.6.1.2. Subcutaneous Implantable Cardioverter Defibrillators (T-ICDs) 7.6.2. External Defibrillators 7.6.2.1. Automated External Defibrillators 7.6.2.2.1. Semi-Automated External Defibrillators 7.6.2.2.2. Fully Automated External Defibrillators 7.6.2.2. Manual External Defibrillators 7.6.2.3. Wearable Cardioverter Defibrillators 7.6.3. Pacemakers 7.6.3.1. Pacemakers Market, By Implantability 7.6.3.3.1. Implantable Pacemakers 7.6.3.3.2. External Pacemakers 7.6.3.1. Pacemakers Market, By Type 7.6.3.3.1. Dual-Chamber Pacemakers 7.6.3.3.2. Single-Chamber Pacemakers 7.6.3.3.3. Biventricular/Crt Pacemakers
8. Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By End-User Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Hospitals 8.2. Clinics, Cardiac Centers and Ambulatory Surgery Centers 8.3. Other End Users
9. North America Cardiac Monitoring and Cardiac Rhythm Management Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 9.2.1. U.S.A 9.2.2. Canada 9.2.3. Mexico 9.3. Market Size (USD Million) Forecast for North America 2022-2028
10. Latin America Cardiac Monitoring and Cardiac Rhythm Management Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. Brazil 10.2.2. Venezuela 10.2.3. Argentina 10.2.4. Rest of Latin America 10.3. Market Size (USD Million) Forecast for Latin America 2022-2028
11. Europe Cardiac Monitoring and Cardiac Rhythm Management Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5. Spain 11.2.6. Russia 11.2.7. Poland 11.2.8. Rest of Europe 11.3. Market Size (USD Million) Forecast for Europe 2022-2028
12. Asia Pacific Cardiac Monitoring and Cardiac Rhythm Management Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Japan 12.2.2. China 12.2.3. India 12.2.4. Australia and New Zealand 12.2.5. ASEAN 12.2.6. Rest of Asia Pacific 12.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
13. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. GCC 13.2.2. Israel 13.2.3. South Africa 13.2.4. Rest of MEA 13.3. Market Size (USD Million) Forecast for MEA 2022-2028
14. Market Share Analysis and Competitive Landscape 14.1. Global Landscape - Key Players, Revenue and Presence 14.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 14.3. Global Emerging Companies 14.4. North America - Market Share Analysis and Key Regional Players 14.5. Europe - Market Share Analysis and Key Regional Players 14.6. Asia Pacific - Market Share Analysis and Key Regional Players 14.7. Global Key Player - Growth Matrix
15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 15.1. Medtronic 15.1.1. Company Overview 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2. Boston Scientific 15.2.1. Company Overview 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3. Abbott Laboratories 15.3.1. Company Overview 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4. GE Healthcare 15.4.1. Company Overview 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5. BIOTRONIK 15.5.1. Company Overview 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6. Koninklijke Philips 15.6.1. Company Overview 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7. Asahi Kasei 15.7.1. Company Overview 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8. MicroPort Scientific 15.8.1. Company Overview 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9. Hill-Rom Holdings 15.9.1. Company Overview 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 15.10.Nihon Kohden 15.10.1. Company Overview 15.10.2. Product Portfolio 15.10.3. SWOT Analysis 15.10.4. Financial Overview 15.10.5. Strategic Overview 15.11.SCHILLER AG 15.11.1. Company Overview 15.11.2. Product Portfolio 15.11.3. SWOT Analysis 15.11.4. Financial Overview 15.11.5. Strategic Overview 15.12.BioTelemetry 15.12.1. Company Overview 15.12.2. Product Portfolio 15.12.3. SWOT Analysis 15.12.4. Financial Overview 15.12.5. Strategic Overview 15.13.BPL Medical Technologies 15.13.1. Company Overview 15.13.2. Product Portfolio 15.13.3. SWOT Analysis 15.13.4. Financial Overview 15.13.5. Strategic Overview 15.14.ACS Diagnostics 15.14.1. Company Overview 15.14.2. Product Portfolio 15.14.3. SWOT Analysis 15.14.4. Financial Overview 15.14.5. Strategic Overview 15.15.Shenzhen Mindray Bio-Medical Electronics 15.15.1. Company Overview 15.15.2. Product Portfolio 15.15.3. SWOT Analysis 15.15.4. Financial Overview 15.15.5. Strategic Overview 15.16.Lepu Medical Technology 15.16.1. Company Overview 15.16.2. Product Portfolio 15.16.3. SWOT Analysis 15.16.4. Financial Overview 15.16.5. Strategic Overview 15.17.Shree Pacetronix 15.17.1. Company Overview 15.17.2. Product Portfolio 15.17.3. SWOT Analysis 15.17.4. Financial Overview 15.17.5. Strategic Overview 15.18.OSYPKA 15.18.1. Company Overview 15.18.2. Product Portfolio 15.18.3. SWOT Analysis 15.18.4. Financial Overview 15.18.5. Strategic Overview 15.19.BTL 15.19.1. Company Overview 15.19.2. Product Portfolio 15.19.3. SWOT Analysis 15.19.4. Financial Overview 15.19.5. Strategic Overview 15.20.Alivecor, Inc. 15.20.1. Company Overview 15.20.2. Product Portfolio 15.20.3. SWOT Analysis 15.20.4. Financial Overview 15.20.5. Strategic Overview 15.21.Amiitalia 15.21.1. Company Overview 15.21.2. Product Portfolio 15.21.3. SWOT Analysis 15.21.4. Financial Overview 15.21.5. Strategic Overview 15.22.Bexen Cardio 15.22.1. Company Overview 15.22.2. Product Portfolio 15.22.3. SWOT Analysis 15.22.4. Financial Overview 15.22.5. Strategic Overview 15.23.Narang Medical Limited 15.23.1. Company Overview 15.23.2. Product Portfolio 15.23.3. SWOT Analysis 15.23.4. Financial Overview 15.23.5. Strategic Overview 15.24.MeTrax GmbH 15.24.1. Company Overview 15.24.2. Product Portfolio 15.24.3. SWOT Analysis 15.24.4. Financial Overview 15.24.5. Strategic Overview 15.25.Progetti Srl 15.25.1. Company Overview 15.25.2. Product Portfolio 15.25.3. SWOT Analysis 15.25.4. Financial Overview 15.25.5. Strategic Overview
16. Pre and Post COVID-19 Impact 16.1. Positive influence on the healthcare industry 16.2. The financial disruption of the manufacturing sector 16.3. Impact of COVID-19 on emerging companies 16.4. Significant mandates in the healthcare regulations initiated by administrations 16.5. The overall economic slowdown of the developing and developed nations
17. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics